154 related articles for article (PubMed ID: 18517280)
21. Differential susceptibility of renal carcinoma cell lines to tumor suppression by exogenous Fhit expression.
Werner NS; Siprashvili Z; Fong LY; Marquitan G; Schröder JK; Bardenheuer W; Seeber S; Huebner K; Schütte J; Opalka B
Cancer Res; 2000 Jun; 60(11):2780-5. PubMed ID: 10850413
[TBL] [Abstract][Full Text] [Related]
22. Epigenetic inactivation of the RASSF1A 3p21.3 tumor suppressor gene in both clear cell and papillary renal cell carcinoma.
Morrissey C; Martinez A; Zatyka M; Agathanggelou A; Honorio S; Astuti D; Morgan NV; Moch H; Richards FM; Kishida T; Yao M; Schraml P; Latif F; Maher ER
Cancer Res; 2001 Oct; 61(19):7277-81. PubMed ID: 11585766
[TBL] [Abstract][Full Text] [Related]
23. Characteristic chromosomal aberrations in sporadic cerebellar hemangioblastomas revealed by comparative genomic hybridization.
Sprenger SH; Gijtenbeek JM; Wesseling P; Sciot R; van Calenbergh F; Lammens M; Jeuken JW
J Neurooncol; 2001 May; 52(3):241-7. PubMed ID: 11519854
[TBL] [Abstract][Full Text] [Related]
24. Clear cell papillary renal cell carcinoma: a clinicopathological study emphasizing ultrastructural features and cytogenetic heterogeneity.
Shi SS; Shen Q; Xia QY; Tu P; Shi QL; Zhou XJ; Rao Q
Int J Clin Exp Pathol; 2013; 6(12):2936-42. PubMed ID: 24294381
[TBL] [Abstract][Full Text] [Related]
25. Chromosome 3p deletion in a renal cell carcinoma cell line established from a patient with von Hippel-Lindau disease.
Kohno T; Sekine T; Tobisu K; Oshimura M; Yokota J
Jpn J Clin Oncol; 1993 Aug; 23(4):226-31. PubMed ID: 8105119
[TBL] [Abstract][Full Text] [Related]
26. Histopathological, cytogenetic, and molecular characterization of renal cortical tumors.
Presti JC; Rao PH; Chen Q; Reuter VE; Li FP; Fair WR; Jhanwar SC
Cancer Res; 1991 Mar; 51(5):1544-52. PubMed ID: 1671759
[TBL] [Abstract][Full Text] [Related]
27. Detection of a germline mutation and somatic homozygous loss of the von Hippel-Lindau tumor-suppressor gene in a family with a de novo mutation. A combined genetic study, including cytogenetics, PCR/SSCP, FISH, and CGH.
Decker HJ; Neuhaus C; Jauch A; Speicher M; Ried T; Bujard M; Brauch H; Störkel S; Stöckle M; Seliger B; Huber C
Hum Genet; 1996 Jun; 97(6):770-6. PubMed ID: 8641695
[TBL] [Abstract][Full Text] [Related]
28. Patterns of gene expression and copy-number alterations in von-hippel lindau disease-associated and sporadic clear cell carcinoma of the kidney.
Beroukhim R; Brunet JP; Di Napoli A; Mertz KD; Seeley A; Pires MM; Linhart D; Worrell RA; Moch H; Rubin MA; Sellers WR; Meyerson M; Linehan WM; Kaelin WG; Signoretti S
Cancer Res; 2009 Jun; 69(11):4674-81. PubMed ID: 19470766
[TBL] [Abstract][Full Text] [Related]
29. Genetic alterations in sporadic renal-cell carcinoma: molecular analyses of tumor suppressor gene harboring chromosomal regions 3p, 5q, and 17p.
Brauch H; Pomer S; Hieronymus T; Schadt T; Löhrke H; Komitowski D
World J Urol; 1994; 12(3):162-8. PubMed ID: 7951344
[TBL] [Abstract][Full Text] [Related]
30. [Development of human renal cell carcinoma (RCC)--the responsible genes for the development of hereditary and sporadic human RCCs].
Shuin T; Kamata M; Ashida S
Gan To Kagaku Ryoho; 2002 Oct; 29(10):1719-25. PubMed ID: 12402420
[TBL] [Abstract][Full Text] [Related]
31. Location of candidate tumour suppressor gene loci at chromosomes 3p, 8p and 9p for oral squamous cell carcinomas.
Partridge M; Emilion G; Pateromichelakis S; Phillips E; Langdon J
Int J Cancer; 1999 Oct; 83(3):318-25. PubMed ID: 10495423
[TBL] [Abstract][Full Text] [Related]
32. Expression of fibronectin and HIF-1alpha in renal cell carcinomas: relationship to von Hippel-Lindau gene inactivation.
He Z; Liu S; Guo M; Mao J; Hughson MD
Cancer Genet Cytogenet; 2004 Jul; 152(2):89-94. PubMed ID: 15262424
[TBL] [Abstract][Full Text] [Related]
33. Role of chromosome 3p12-p21 tumour suppressor genes in clear cell renal cell carcinoma: analysis of VHL dependent and VHL independent pathways of tumorigenesis.
Martinez A; Fullwood P; Kondo K; Kishida T; Yao M; Maher ER; Latif F
Mol Pathol; 2000 Jun; 53(3):137-44. PubMed ID: 10897333
[TBL] [Abstract][Full Text] [Related]
34. Interstitial deletions including chromosome 3 common eliminated region 1 (C3CER1) prevail in human solid tumors from 10 different tissues.
Petursdottir TE; Thorsteinsdottir U; Jonasson JG; Moller PH; Huiping C; Bjornsson J; Egilsson V; Imreh S; Ingvarsson S
Genes Chromosomes Cancer; 2004 Nov; 41(3):232-42. PubMed ID: 15334546
[TBL] [Abstract][Full Text] [Related]
35. Detection of deletions in the short arm of chromosome 3 in uncultured renal cell carcinomas by interphase cytogenetics.
Siebert R; Jacobi C; Matthiesen P; Zühlke-Jenisch R; Potratz C; Zhang Y; Stöckle M; Klöppel G; Grote W; Schlegelberger B
J Urol; 1998 Aug; 160(2):534-9. PubMed ID: 9679924
[TBL] [Abstract][Full Text] [Related]
36. A novel approach to simultaneously scan genes at fragile sites.
Willem P; Brown J; Schouten J
BMC Cancer; 2006 Aug; 6():205. PubMed ID: 16895604
[TBL] [Abstract][Full Text] [Related]
37. FHIT gene and the FRA3B region are not involved in the genetics of renal cell carcinomas.
Bugert P; Wilhelm M; Kovacs G
Genes Chromosomes Cancer; 1997 Sep; 20(1):9-15. PubMed ID: 9290948
[TBL] [Abstract][Full Text] [Related]
38. Genomic alterations and instabilities in renal cell carcinomas and their relationship to tumor pathology.
Thrash-Bingham CA; Salazar H; Freed JJ; Greenberg RE; Tartof KD
Cancer Res; 1995 Dec; 55(24):6189-95. PubMed ID: 8521412
[TBL] [Abstract][Full Text] [Related]
39. Comprehensive allelotyping of human renal cell carcinomas using microsatellite DNA probes.
Thrash-Bingham CA; Greenberg RE; Howard S; Bruzel A; Bremer M; Goll A; Salazar H; Freed JJ; Tartof KD
Proc Natl Acad Sci U S A; 1995 Mar; 92(7):2854-8. PubMed ID: 7708737
[TBL] [Abstract][Full Text] [Related]
40. Renal cell tumors with clear cell histology and intact VHL and chromosome 3p: a histological review of tumors from the Cancer Genome Atlas database.
Favazza L; Chitale DA; Barod R; Rogers CG; Kalyana-Sundaram S; Palanisamy N; Gupta NS; Williamson SR
Mod Pathol; 2017 Nov; 30(11):1603-1612. PubMed ID: 28731045
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
